share print

Our business model

The world is changing and our highly regulated industry is constantly undergoing transformation. To continue to thrive as a business, we must look ahead, and understand the trends and forces that will shape our business in the future.


Thanks to our comprehensive business model, we are able to navigate with precision and skill our highly regulated industry and stay one step ahead. We strive to innovate and as such, we are constantly driving forward to identify drugs, devices and biotech products with meaningful clinical benefits. While our primary focus is on therapeutic categories, such as women's health, consumer health, endocrinology and oncology, we pride ourselves on being flexible in the pursuit of treatments, which is why we are always on the lookout for new opportunities outside of these core, focus areas.

Our drive to innovate pushed us to launch HRA Insight™ (Initiative to Seed Innovation today to Grow HRA tomorrow).

HRA Insight™ is born out of the understanding that external vision stimulates innovation over the long term. The initiative will provide seed funding for early-stage projects that fit with HRA’s strategic goals. Its focus will be on healthcare-related projects, including, but not limited to, new chemical entities, biotechnology, devices, delivery systems, healthcare technology, etc.
HRA Insight™  is complementary to our ongoing business development activities lead by our SPOT* team (*Strategic Product Opportunities Team).
We seek to expand our portfolio and pipeline via the acquisition of promising products and technologies.

closeyou are leaving hra pharma
You are now leaving and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?